Women & Activity

Better Nutrition, Nov, 2000

> On August 2, 2000, Chatsworth, Calif.-based Natrol announced positive study results using its trademarked joint product, CetylPure, or more specifically: Cetyl Myristoleate Complex (CMC). In the pilot study, women aged 20 to 55 were tested over a 4-week treatment period. Women given CetylPure experienced "improved physical activity." Elliott Balbert, Natrol's president, said that "the pfiot study will be expanded through further clinical study as we work to find better ways to improve joint health."